Karl August Folkers

Karl August Folkers's AcademicInfluence.com Rankings

Karl August Folkers

Chemistry

#600

World Rank

#1042

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Why Is Karl August Folkers Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Karl August Folkers's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. (1969) (490)
Crystalline Vitamin B12. (1948) (457)
A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. (1983) (423)
Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide. (1971) (377)
Lovastatin decreases coenzyme Q levels in humans. (1990) (334)
Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. (1985) (269)
A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation (1981) (248)
Hydrogenolysis of Sulfur Compounds by Raney Nickel Catalyst (1943) (202)
Biological evaluation of substance P antagonists (1984) (177)
RESEARCHES ON PYRIMIDINES. CXXX. SYNTHESIS OF 2-KETO-1,2,3,4-TETRAHYDROPYRIMIDINES (1932) (163)
A synthetic peptide that is a bombesin receptor antagonist (1984) (159)
Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activity. (1974) (144)
Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10. (1985) (144)
Inhibition of antidromic and substance P-induced vasodilatation by a substance P antagonist. (1981) (142)
A synthetic peptide as an antagonist of substance P (1981) (138)
Inhibition of gastric acid secretion in dogs by neurotensin. (1976) (137)
Lovastatin decreases coenzyme Q levels in rats. (1990) (136)
Sensory and motor functions of spinal cord substance P. (1981) (129)
A substance P antagonist, [D-Pro2, D-Trp7,9]SP, inhibits inflammatory responses in the rabbit eye. (1981) (129)
Discovery of modification of the synthetic tripeptide-sequence of the thyrotropin releasing hormone having activity. (1969) (128)
Researches on Pyrimidines. CXXXVI. The Mechanism of Formation of Tetrahydropyrimidines by the Biginelli Reaction1 (1933) (127)
Inhibition of gastric and intestinal motor activity in dogs by (Gln4) neurotensin. (1977) (127)
Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. (1994) (126)
The roles of coenzyme Q10 and vitamin E on the peroxidation of human low density lipoprotein subfractions. (1995) (120)
Chemical design of antagonists of substance P. (1981) (119)
Treatment of essential hypertension with coenzyme Q10. (1994) (119)
Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy. (1990) (115)
COENZYME Q. I. STRUCTURE STUDIES ON THE COENZYME Q GROUP (1958) (114)
The Chemistry of Vitamin B6. VI. Pyridoxylamino Acids1 (1948) (113)
Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. (1995) (105)
Activities of vitamin Q10 in animal models and a serious deficiency in patients with cancer. (1997) (102)
Coenzyme Q. VII. Isolation and Distribution of Coenzyme Q10 in Animal Tissues (1959) (101)
Cigarette smoke-induced airway oedema due to activation of capsaicin-sensitive vagal afferents and substance P release (1983) (101)
Pantothenic Acid. VIII. The Total Synthesis of Pure Pantothenic Acid (1940) (101)
Presence of substance P-like immunoreactivity in plasma from man and dog. (1975) (98)
Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. (1994) (98)
Analgesic effect of antagonists of substance P. (1981) (97)
Porcine thyrotropin releasing hormone is (pyro)glu-his-pro(NH2). (1970) (95)
Evidence for a deficiency of coenzyme Q10 in human heart disease. (1970) (94)
Usefulness of coenzyme Q10 in clinical cardiology: a long-term study. (1994) (91)
Immunohistochemical evidence for a "neurotoxic" action of (D-Pro2, D-Trp7,9)-substance P, an analogue with substance P antagonistic activity. (1981) (91)
Vitamins and Coenzymes (1975) (90)
Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophies. (1995) (89)
The pharmacological profile of a substance P (SP) antagonist. Evidence for the existence of subpopulations of SP receptors. (1983) (89)
Hadacidin, a new growth-inhibitory substance in human tumor systems. (1962) (86)
Intrathecal (D-Pro2, D-Trp7,9)-SP elicits hypoalgesia and motor blockade in the rat and antagonizes noxious responses induced by substance P. (1982) (86)
INHIBITION OF INFLUENZA VIRUS MULTIPLICATION BY N-GLYCOSIDES OF BENZIMIDAZOLES (1954) (84)
D-4-AMINO-3-ISOXAZOLIDONE, A NEW ANTIBIOTIC* (1955) (80)
β-HYDROXY-β-METHYL-δ-VALEROLACTONE (DIVALONIC ACID), A NEW BIOLOGICAL FACTOR (1956) (78)
Identification of cordycepin, a metabolite of Cordyceps militaris, as 3'-deoxyadenosine. (1964) (78)
Vitamin B12, A Cobalt Complex. (1948) (77)
The activities of coenzyme Q10 and vitamin B6 for immune responses. (1993) (77)
THE PREPARATION OF COPPER-CHROMIUM OXIDE CATALYSTS FOR HYDROGENATION (1931) (74)
Spantide II, a novel tachykinin antagonist, and galanin inhibit plasma extravasation induced by antidromic C-fiber stimulation in rat hindpaw (1991) (74)
Phosphates of the vitamin B6 group. 1. The structure of codecarboxylase. (1951) (72)
Cardiovascular and metabolic actions of neurotensin and (Gln4)-Neurotensin. (1976) (70)
Substance P- antagonists: a new type of pharmacological tool (1982) (70)
The Reactions of Lignin with Alkaline Hydrogen Peroxide. Part II. Factors Influencing the Decomposition of Phenolic Structures. (1979) (69)
Piericidin A: a new inhibitor of mitochondrial electron transport. (1966) (69)
Low molecular weight analogs of coenzyme Q as hydrogen acceptors and donors in systems of the respiratory chain. (1975) (69)
Comparative Data on Vitamin B12 From Liver and From a New Source, Streptomyces griseus. (1948) (69)
The site of inhibition of mitochondrial electron transfer by coenzyme Q analogues. (1978) (69)
A substance P antagonist inhibits a slow reflex response in the spinal cord of the newborn rat. (1982) (68)
Adriamycin cardiotoxicity: early detection by systolic time interval and possible prevention by coenzyme Q10. (1978) (68)
Effect of topical application of coenzyme Q10 on adult periodontitis. (1994) (67)
Spantide II, an effective tachykinin antagonist having high potency and negligible neurotoxicity. (1990) (67)
Survival of cancer patients on therapy with coenzyme Q10. (1993) (66)
Pharmacological characterization of four related substance P antagonists. (1982) (66)
Properties and Derivatives of α-Lipoic Acid (1956) (65)
Design, synthesis and bioassays of antagonists of LHRH which have high antiovulatory activity and release negligible histamine. (1987) (65)
Mass spectra of ubiquinones and ubiquinols. (1967) (62)
ISOLATION OF ERYTHROIDINE, AN ALKALOID OF CURARE ACTION, FROM ERYTHRINA AMERICANA MILL. (1937) (62)
Observations on Silver Trifluoromethane Sulfonate-promoted Syntheses of 1,2-trans-Glycosides from Acylated Glycosyl Bromides. (1979) (62)
Alkaloids of Dichroa febrifuga Lour. (1948) (61)
Further evidence that TRH is also a physiological regulator of PRL secretion in man. (1973) (61)
Luteinizing hormone-releasing hormone involvement in the reproductive behavior of a male amphibian. (1982) (60)
RELATIONSHIP BETWEEN STRUCTURE OF BENZIMIDAZOLE DERIVATIVES AND SELECTIVE VIRUS INHIBITORY ACTIVITY : INHIBITION OF POLIOVIRUS MULTIPLICATION AND CYTOPATHIC EFFECTS BY 2-(α-HYDROXYBENZYL)-BENZIMIDAZOLE, AND ITS 5-CHLORO DERIVATIVE (1961) (59)
THE STRUCTURE OF BIOTIN: A STUDY OF DESTHIOBIOTIN (1942) (59)
Deficiency of coenzyme Q 10 in human heart disease. I. (1972) (58)
THE STRUCTURE AND SYNTHESIS OF PYRIDOXAMINE AND PYRIDOXAL (1944) (57)
Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10. (1985) (56)
Plasma concentration of neurotensin-like immunoreactivity (NTLI) and lower esophageal sphincter (LES) pressure in man following infusion of (Gln4)-neurotensin. (1980) (56)
Kinetics of the reoxidation of succinate dehydrogenase. (1977) (56)
Biological evidence that separate hypothalamic hormones release the follicle stimulating and luteinizing hormones (1973) (55)
Inhibition of mitochondrial electron transport by piericidin A and related compounds. (1968) (55)
Coenzyme Q10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure. (1990) (55)
Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure. (1985) (55)
Behavioural and antinociceptive effects of intrathecally injected substance P analogues in mice. (1985) (54)
Complete Sequence of Biosynthesis from p-Hydroxybenzoic Acid to Ubiquinone1 (1966) (54)
Treatment of hypertrophic cardiomyopathy with coenzyme Q10. (1997) (54)
Isolation of a New Acetate-replacing Factor (1956) (54)
COENZYME Q. II. SYNTHESIS OF 6-FARNESYL- AND 6-PHYTYL-DERIVATIVES OF 2,3-DIMETHOXY-5-METHYLBENZOQUINONE AND RELATED ANALOGS (1958) (53)
Deficiency of coenzyme Q 10 in gingival tissue from patients with periodontal disease. (1971) (53)
Vitamin B12: reactions of cyano-cobalamin and related compounds. (1950) (53)
Plasticity of the peptidergic mediation of spinal reflex facilitation after peripheral nerve section in the rat (1990) (51)
The specific antagonistic effect of intrathecal spantide II on substance P- and C-fiber conditioning stimulation-induced facilitation of the nociceptive flexor reflex in rat (1990) (51)
Synthesis of DL-3,5-Dihydroxy-3-methylpentanoic Acid (Mevalonic Acid) (1957) (51)
Bioenergetics in clinical medicine: prevention by forms of coenzyme Q of the inhibition by adriamycin of coenzyme Q10-enzymes in mitochondria of the myocardium. (1976) (51)
VITAMIN B12. VI. 5,6-DIMETHYLBENZIMIDAZOLE, A DEGRADATION PRODUCT OF VITAMIN B12 (1949) (50)
Characterization of vitamin K9(H) from Mycobacterium phlei. (1963) (50)
DISCOVERY OF A NEW ACETATE-REPLACING FACTOR (1956) (49)
Coenzyme Q. 17. Isolation of coenzyme Q10 from bacterial fermentation. (1960) (49)
Interaction of substance P antagonists with substance P receptors on dispersed pancreatic acini. (1984) (49)
Biochemical deficiencies of coenzyme Q10 in HIV-infection and exploratory treatment. (1988) (49)
Antide and related antagonists of luteinizing hormone release with long action and oral activity. (1988) (49)
Synthesis of the luteinizing releasing hormone of the hypothalamus and its hormonal activity. (1971) (49)
Actions of neurotensin and (Gln4)-neurotensin on isolated tissues. (2009) (48)
COENZYME Q. VIII. STRUCTURE STUDIES ON A PLANT QUINONE (1959) (48)
Chemistry of vitamin B6. 1. Tautomerism. (1940) (47)
Vitamin B12: the identification of vitamin B12 as a cyano-cobalt coordination complex. (1950) (47)
SYNTHESIS OF D-4-AMINO-3-ISOXAZOLIDONE (1955) (46)
Competitive inhibition of benzodiazepine binding by fractions from porcine brain. (1978) (46)
Discovery of inhibitory activity of tenuazonic acid for growth of human adenocarcinoma-1. (1963) (46)
A substance P antagonist blocks non-cholinergic slow excitatory postsynaptic potential in guinea-pig sympathetic ganglia. (1983) (45)
Isolation and inhibitory effects of KB cell cultures of 3'-deoxyandenosine from Aspergillus nidulans (Eidam) Wint. (1964) (45)
Researches on Pyrimidines. CXXXIII. Some Reactions and Derivatives of 2-Keto-4-phenyl-5-carbethoxy-6-methyl-1,2,3,4-tetrahydropyrimidine (1933) (45)
Design and synthesis of effective antagonists of substance P. (1982) (45)
Synthesis and some biological activities of substance P. (1974) (45)
Inhibition of antidromically induced stimulation of gastric motility by substance P receptor blockade. (1983) (45)
Vitamin B12. XVI.1,2 Modifications of Cyano-cobalamin (1951) (45)
VITAMIN B12. IX. 1-α-D-RIBOFURANOSIDO-5,6-DIMETHYLBENZIMIDAZOLE, A DEGRADATION PRODUCT OF VITAMIN B12 (1950) (44)
High-pressure liquid chromatography of peptides. (1977) (44)
Vitamin B12. IV.1 Further Characterization of Vitamin B12 (1949) (43)
Clinical results of a cross-over treatment with pyridoxine and placebo of the carpal tunnel syndrome. (1979) (43)
Low-dose intrathecal morphine facilitates the spinal flexor reflex by releasing different neuropeptides in rats with intact and sectioned peripheral nerves (1991) (43)
VITAMIN B12.V. IDENTIFICATION OF CRYSTALLINE VITAMIN B12a (1949) (43)
Discovery of ubiquinones-1,-2,-3, and -4 and the nature of biosynthetic isoprenylation. (1967) (42)
A deficiency of vitamin B6 is a plausible molecular basis of the retinopathy of patients with diabetes mellitus. (1991) (42)
Chemistry of Vitamin B6. VIII. Additional Pyridoxylideneamines and Pyridoxylamines (1952) (42)
Synthesis of alkyl-4,7-dioxobenzothiazoles with prophylactic antimalarial activity. (1973) (41)
Coenzyme Q10, alpha-tocopherol and free cholesterol in HDL and LDL fractions. (1991) (41)
Streptomyces antibiotics; dihydrostreptomycin. (1946) (41)
Dietary coenzyme Q10 supplementation alters platelet size and inhibits human vitronectin (CD51/CD61) receptor expression. (1997) (40)
The synthesis of tenuazonic and congeneric tetramie acids. (1965) (40)
Study of CoQ10-enzymes in gingiva from patients with periodontal disease and evidence for a deficiency of coenzyme Q10. (1974) (40)
Lovastatin decreases coenzyme Q levels in rats. (1990) (40)
Allenes and Acetylenes. XVIII. Synthesis of 3-Pyrrolines by Silver(I)-catalyzed Cyclization of Allenic Amines. (1979) (40)
Synthesis and activities of neurotensin, and its acid and amide analogs: possible natural occurrence of [Gln4]-neurotensin. (1976) (39)
Bioenergetics in clinical medicine. II. Adjunctive treatment with coenzyme Q in periodontal therapy. (1975) (39)
Response of vitamin B-6 deficiency and the carpal tunnel syndrome to pyridoxine. (1982) (39)
Activity and specificity of synthetic thyrotropin-releasing hormone in man. (1970) (39)
Synthesis of Cycloserine and a Methyl Analog (1957) (39)
COENZYME Q. LXII. STRUCTURE AND SYNTHESIS OF RHODOQUINONE, A NATURAL AMINOQUINONE OF THE COENZYME Q GROUP. (1965) (39)
STREPTOMYCES ANTIBIOTICS. XXIII. 1,3-DIAMINO-4,5,6-TRIHYDROXYCYCLOHEXANE FROM NEOMYCIN A. (1951) (38)
NOVOBIOCIN. II. STRUCTURE OF NOVOBIOCIN (1956) (38)
Inhibition of acid secretion from vagally innervated and denervated gastric pouches by (Gln4)-neurotensin. (1980) (38)
Relevance of the biosynthesis of coenzyme Q10 and of the four bases of DNA as a rationale for the molecular causes of cancer and a therapy. (1996) (38)
COENZYME Q. XI. THE STRUCTURE OF SOLANESOL (1959) (37)
Spantide II, a novel tachykinin antagonist having high potency and low histamine-releasing effect (1990) (37)
Inhibition by adriamycin of the mitochondrial biosynthesis of coenzyme Q10 and implication for the cardiotoxicity of adriamycin in cancer patients. (1977) (37)
Erythrina Alkaloids. III. Isolation and Characterization of a New Alkaloid, Erythramine (1939) (37)
Structure of Vitamin B6. II (1939) (37)
Determination of Structure of ,d-Dihydroxy--methylvaleric Acid (1957) (37)
The effect of obstruction of the ureter on the renal localisation of bacteria. (1956) (36)
Identification of Plastoquinone-3 from Chloroplasts1 (1965) (36)
Deficiency of coenzyme Q10 in myocardial failure (1984) (36)
Vasopressor effects of substance P and C-terminal sequences after intracisternal injection to alpha-chloralose-anaesthetized rats: blockade by a substance P antagonist. (1982) (36)
Luteinizing releasing hormone, synthesis and arg 8 -analogs, and conformation-sequence-activity relationships. (1972) (35)
COENZYME Q. X. SYNTHESIS OF COENZYME Q9, 2,3-DIMETHYL-5-SOLANESYLBENZOQUINONE (Q·254), AND A VITAMIN K ANALOG (1959) (35)
Inhibitory analogues of the luteinizing hormone-releasing hormone having D-aromatic residues in positions 2 and 6 and variation in position 3. (1978) (35)
Bioenergetics in clinical medicine. Studies on coenzyme Q10 and essential hypertension. (1975) (35)
Effective treatment with coenzyme Q10 of patients with chronic myocardial disease. (1985) (35)
Rhodanine: A Selective Inhibitor of the Multiplication of Echovirus 12 (1970) (35)
Bioenergetics in clinical medicine. VI. adjunctive treatment of periodontal disease with coenzyme Q10. (1976) (34)
Myocardial preservation by therapy with coenzyme Q10 during heart surgery (2004) (34)
Characterization of two substance P antisera. (1982) (34)
Coenzyme Q10 increases T4/T8 ratios of lymphocytes in ordinary subjects and relevance to patients having the AIDS related complex. (1991) (34)
Rescue by coenzyme Q10 from electrocardiographic abnormalities caused by the toxicity of adriamycin in the rat. (1978) (34)
Synthesis, Structure and Stability of Nicotine Delta1'(5') Iminium Ion, an Intermediary Metabolite of Nicotine. (1979) (33)
2-DECAPRENYLPHENOL, BIOSYNTHETIC PRECURSOR OF UBIQUINONE-10. (1965) (33)
Synthesis of (+)-α-Lipoic Acid and its Optical Antipode1 (1954) (33)
Inhibition of influenza virus multiplication by alkyl derivatives of benzimidazole. II. Measurement of inhibitory activity by hemagglutination titrations. (1953) (33)
Structural Requirements of Selective Inhibition of Enteroviruses by 2-(α-Hydroxybenzyl)-benzimidazole and Related Compounds (1969) (33)
Studies on Carcinolytic Compounds. I. 6,7-Dichloro-9-(1'-D-sorbityl)-isoalloxazine (1950) (32)
Synthetic thyrotropin-releasing hormone. Activity in men and women, specificity of action, inhibition by triiodothyronine, and activity orally. (1971) (32)
Chemistry of Vitamin B6. VII. Pyridoxylidene- and Pyridoxylamines1 (1948) (31)
Quantitative determination of coenzyme Q10 in human blood for clinical studies. (1984) (31)
BIOENERGETICS IN CLINICAL MEDICINE (1976) (31)
On the presence and significance of coenzyme Q in microsomes. (1962) (31)
α,β-Dihydroxyisovaleric Acid and α,β-Dihydroxy-β-methylvaleric Acid, Precursors of Valine and Isoleucine1,2 (1954) (31)
Inhibition of coenzyme Q systems by chloroquine and other antimalarials. (1968) (31)
Structure of Rhodoquinone1 (1966) (31)
Biochemical evidence for a deficiency of vitamin B6 in the carpal tunnel syndrome based on a crossover clinical study. (1978) (31)
Synthesis and relationship of L-glutaminyl-L-histidyl-L-prolinamide to the thyrotropin releasing hormone. (1970) (31)
Therapy with Coenzyme Q10 for Patients with Periodontal Disease (1993) (31)
Erythrina Alkaloids. VII. Isolation and Characterization of the New Alkaloids, Erythraline and Erythratine (1940) (30)
Coenzyme Q. IX. Coenzyme Q9 and Q10 content of dietary components. (1959) (30)
STREPTOMYCES ANTIBIOTICS. XXIII. ISOLATION OF NEOMYCIN A (1949) (30)
Increase in levels of IgG in serum of patients treated with coenzyme Q10. (1982) (30)
Isolated diastolic dysfunction of the myocardium and its response to CoQ10 treatment (2004) (30)
The effect of oral coenzyme Q10 on the exercise tolerance of middle-aged, untrained men (1995) (30)
Coenzyme Q. XII. Ethoxy Homologs of Coenzyme Q10. Artifact of Isolation (1959) (30)
Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant. (1992) (30)
INHIBITION OF INFLUENZA VIRUS MULTIPLICATION BY ALKYL DERIVATIVES OF BENZIMIDAZOLE (1953) (29)
Contraception and inhibition of ovulation by minipump infusion of the luteinizing hormone releasing hormone, active analogs and antagonists. (1976) (29)
Deficiency of coenzyme Q10 in hypertensive rats and reduction of deficiency by treatment with coenzyme Q10. (1974) (29)
HIGH INHIBITORY ACTIVITY OF CERTAIN HALOGENATED RIBOFURANOSYLBENZIMIDAZOLES ON INFLUENZA B VIRUS MULTIPLICATION (1956) (29)
Identification of two different Q-binding sites in QH2-cytochrome c oxidoreductase, using the Q analogue n-heptadecylmercapto-6-hydroxy-5,8-quinolinequinone. (1982) (29)
Antinociceptive and substance P antagonistic effects of intrathecally injected spantide II in rat: no signs of motor impairment or neurotoxicity (1990) (29)
Hydrogenation of Cyclic Ureides under Elevated Temperatures and Pressures. I.1 2-Keto-1,2,3,4-tetrahydropyrimidines (1934) (29)
A six-year clinical study of therapy of cardiomyopathy with coenzyme Q10. (1990) (29)
Biosynthesis of ubiquinones by malarial parasites. I. Isolation of [14C]ubiquinones from cultures of rhesus monkey blood infected with Plasmodium knowlesi. (1969) (29)
The Synthesis of 3-Hydroxy-2-(3)-benzofuranone and of 4-Hydroxymandelic Acid (1936) (29)
Bioenergetics in clinical medicine. IX. Gingival and leucocytic deficiencies of coenzyme Q10 in patients with periodontal disease. (1976) (28)
Novobiocin. VIII. The Configuration of Noviose (1958) (28)
Bioenergetics in clinical medicine. XI. Studies on coenzyme Q and diabetes mellitus. (1976) (28)
Antagonists of the luteinizing hormone releasing hormone with pyridyl-alanines which completely inhibit ovulation at nanogram dosage. (1983) (28)
Coenzyme Q10 content in different parts of the normal human heart. (1988) (28)
Inhibition of Influenza Virus Multiplication by 2,5-Dimethylbenzimidazole * (1952) (28)
Coenzyme Q. XXIV. On the significance of coenzyme Q10 in human tissues. (1961) (28)
SYNTHETIC VITAMIN B6. (1939) (27)
Streptomyces Antibiotics. XV. N-Methyl-L-glucosamine (1947) (27)
Biotin. II. Synthesis of Biotin (1944) (27)
Erythrina Alkaloids. X. Isolation and Characterization of Erysonine and Other Liberated Alkaloids (1941) (27)
Novobiocin. III. Cyclonovobiocic Acid, a Methyl Glycoside, and Other Reaction Products (1956) (27)
Activity of spantide I and II at various tachykinin receptors and NK-2 tachykinin receptor subtypes. (1991) (27)
The oxidative dimerization of alpha-,beta-, gamma-, and delta-tocopherols. (1968) (27)
A substance P antagonist inhibits heat-induced oedema in the rat skin. (1984) (27)
Bioenergetics in clinical medicine. XVI. Reduction of hypertension in patients by therapy with coenzyme Q10. (1981) (27)
Deficiency of coenzyme Q in gingiva of patients with periodontal disease. (1973) (27)
The involvement of substance P in the vagal control of the feline pylorus. (1982) (27)
Hydrogenation by Raney Nickel Catalyst without Gaseous Hydrogen (1944) (27)
Erythrina Alkaloids. IX. Isolation and Characterization of Erysodine, Erysopine, Erysocine and Erysovine (1940) (27)
A one year bioavailability study of coenzyme Q10 with 3 months withdrawal period. (1994) (26)
CATHOMYCIN. I. ISOLATION AND CHARACTERIZATION (1955) (26)
Antimetabolites of coenzyme Q. Their potential application as antimalarials. (1974) (26)
Presence of proline in position 3 for potent inhibition of the activity of the luteinizing hormone releasing hormone and of ovulation. (1976) (26)
Bioenergetics in clinical medicine. VIII. Adminstration of coenzyme Q10 to patients with essential hypertension. (1976) (26)
Biotin l-sulfoxide. 3. The characterization of biotin l-sulfoxide from a microbiological source. (1954) (26)
Studies on Carcinolytic Compounds. V. 6,7-Dimethyl-9-[1'-(5-desoxy-D-ribityl)]-isoalloxazine (1955) (25)
Synthesis of analogs of the thyrotropin-releasing hormone and structure-activity relationship. (1971) (25)
Vitamin B12. VIII. Vitamin B12-Like Activity of 5,6-Dimethylbenzimidazole and Tests on Related Compounds (1950) (25)
STREPTOMYCES ANTIBIOTICS. III. DEGRADATION OF STREPTOMYCIN TO STREPTOBIOSAMINE DERIVATIVES. (1945) (25)
Vitamin E deficiency in the monkey. VII. The role of vitamin E and the vitamin-like activity of coenzyme Q. (1965) (25)
Coenzyme Q. XIII. Isolation, assay and human urinary levels of coenzyme Q10. (1960) (25)
Evaluation of the anaphylactoid activity of a new LHRH antagonist. (1988) (24)
Improved and effective assays of the glutamic oxaloacetic transaminase by the coenzyme-apoenzyme system (CAS) principle. (1976) (24)
The effect of oral coenzyme Q10 on the exercise tolerance of middle-aged, untrained men. (1992) (24)
STREPTOMYCES ANTIBIOTICS. I. CRYSTALLINE SALTS OF STREPTOMYCIN AND STREPTOTHRICIN. (1945) (24)
Discovery of a new synthetic tetrapeptide having luteinizing releasing hormone (LRH) activity. (1971) (24)
Vitamin B12. 11. Degradation of vitamin B12 to Dg-l-amino-2-propanoL. (1950) (24)
Structure and synthesis of the thyrotropin-releasing hormone. (1971) (24)
On the Role of Substance P, Galanin, Vasoactive Intestinal Peptide, and Calcitonin Gene—related Peptide in Mediation of Spinal Reflex Excitability in Rats with Intact and Sectioned Peripheral Nerves a (1991) (24)
Biosynthesis and evidence for the existence of the follicle stimulating hormone releasing hormone. (1973) (24)
Partial reactivation of impaired immune competence in aged mice by synthetic thymus factors. (1978) (24)
Antimetabolites of coenzyme Q. 16. New alkylmercaptoquinones having antimalarial curative activity. (1973) (24)
Comparison of spantide II and CP-96,345 for blockade of tachykinin-evoked contractions of smooth muscle. (1991) (24)
Increased potency of antagonists of the luteinizing hormone releasing hormone which have D-3-Pal in position 6. (1986) (23)
INHIBITION OF INFLUENZA VIRUS MULTIPLICATION BY ALKYL DERIVATIVES OF BENZIMIDAZOLE (1953) (23)
Micro-analysis for coenzyme Q10 in endomyocardial biopsies of cardiac patients and data on bovine and canine hearts. (1984) (23)
On the chemical existence and partial purification of the hypothalamic follicle stimulating hormone releasing hormone. (1973) (23)
Plasma ubiquinone, alpha-tocopherol and cholesterol in man. (1992) (23)
Response of genetically dystrophic mice to therapy with hexahydrocoenzyme Q4. (1966) (23)
Isolation and Some Chemical Properties of Grisein (1951) (23)
C24-, C22-, C20- and C18-Macrocyclic Lactones in Halictide Bees. (1979) (22)
SYNTHESIS AND BIOLOGICAL ACTIVITY OF ANALOGS OF SUBSTANCE P, MODIFIED FOR CONFORMATIONAL INFORMATION BY D-AMINO ACIDS (1979) (22)
Effective and safe therapy with coenzyme Q10 for cardiomyopathy (1988) (22)
Isolation of crystalline biocytin from yeast extract. (1952) (22)
Purification of a prolactin inhibiting hormone and the revealing of hormone D-GHIH which inhibits the release of growth hormone. (1974) (22)
Deficiency of coenzyme Q 10 in human heart disease. II. (1972) (22)
Research on coenzyme Q10 in clinical medicine and in immunomodulation. (1985) (22)
The Structure of a New Product from Yeast: 2-(6-Hydroxy-2-methoxy-3,4-methylenedioxyphenyl)-benzofuran (1959) (22)
Coenzyme Q. XLVIII. Data on Quinone Methines as Reaction Intermediates and their Possible Role in Oxidative Phosphorylation (1963) (22)
Activity-structure relationships of the thyrotropin releasing hormone. (1970) (22)
Novobiocin. VI. Structure of the Coumarin Moiety (1958) (22)
Synthesis of the luteinizing-releasing hormone of the hypothalamus and the 8-lysine analog. (1972) (22)
Improved methodology to assay carnitine and levels of free and total carnitine in human plasma. (1991) (22)
Novobiocin. VII. Synthesis of Novobiocic Acid, Dihydronovobiocic Acid and Cyclonovobiocic Acid (1958) (21)
Chemistry of vitamin B12. (1954) (21)
Two syntheses of the luteinizing hormone releasing hormone of the hypothalamus. (1972) (21)
Synthesis of 2-multiprenylphenols and 2-multiprenyl-6-methoxyphenols, biosynthetic precursors of the ubiquinones (1967) (21)
Synthesis and some biological activities of the tyrosine-8 analog of substance P. (1976) (21)
Determination and levels of coenzyme Q10 in human blood. (1968) (21)
Bioenergetics in clinical medicine XV. Inhibition of coenzyme Q10-enzymes by clinically used adrenergic blockers of beta-receptors. (1977) (20)
Mass spectra of underivatized peptide amides related to substance P. (1977) (20)
On the inhibitory effects of luteinizing hormone-releasing hormone analogs. (1980) (20)
Enzyme Activities of the Mannitol Cycle and Some Connected Pathways in Alternaria alternata, with Comments on the Regulation of the Cycle. (1979) (20)
Synthesis of Some Bromophenols Present in Red Algae. (1979) (20)
Specificity of inhibition of coenzyme Q-enzyme systems by lipoidal benzoquinone derivatives. (1972) (20)
The potential of coenzyme Q 10 (NSC-140865) in cancer treatment. (1974) (20)
On the role of the histidine moiety in the structure of the thyrotropin-releasing hormone. (1972) (20)
STREPTOMYCES ANTIBIOTICS. II. CRYSTALLINE STREPTOMYCIN TRIHYDROCHLORIDE—CALCIUM CHLORIDE DOUBLE SALT (1945) (20)
2-multiprenylphenols and 2-decaprenyl-6-methoxyphenol, biosynthetic precursors of ubiquinones. (1966) (20)
Erythrina Alkaloids. XIV. Isolation and Characterization of Erysothiovine and Erysothiopine, New Alkaloids Containing Sulfur1a (1944) (20)
RESOLUTION OF DL-MEVALONIC ACID AND THE SYNTHESIS AND BIOLOGICAL ACTIVITIES OF DL-3-HYDROXY-3-METHYLGLUTARALDEHYDIC ACID (1957) (19)
Antimalarial quinones for prophylaxis based on a rationale of inhibition of electron transfer in Plasmodium. (1974) (19)
Determination of biosynthetic precursors from p-hydroxybenzoic acid-U-14C to ubiquinone. (1968) (19)
Antimetabolites of coenzyme Q. 14. Quinolinequinone analogs which inhibit mitochondrial DPNH-oxidase and succinoxidase. (1973) (19)
Synthesis of new 5,8-quinolinequinones as inhibitors of coenzymes Q and as antimalarials. (1971) (19)
Organic structural specificity of coenzyme Q for biological activity. (1966) (19)
Coenzyme Q. CXXII. Identification of ubiquinone-8 biosynthesized by Plasmodium knowlesi, P. cynomolgi, and P. berghei. (1970) (19)
New tocopherol dimers. (1968) (19)
COENZYME Q. LI. NEW DATA ON THE DISTRIBUTION OF COENZYME Q IN NATURE. (1964) (18)
Intranigral substance P stimulation of striatal dopamine release is inhibited by Spantide II: a new tachykinin antagonist without apparent neurotoxicity (1990) (18)
The Response of the Anemic and Dystrophic Monkey to Treatment with Coenzyme Q (1962) (18)
In Vitro Histamine Release with LHRH Analogs (1987) (18)
Field desorption mass spectrometry using needleless emitters. A study of five synthetic tripeptides as hormone models (1978) (18)
Synthesis of the thyrotropin-releasing hormone. (1971) (18)
Syntheses of pyroglutamylhistidylprolinamide and unusual mass fragmentation. (1971) (18)
Evidence for enhanced treatment of periodontal disease by therapy with coenzyme Q. (1973) (18)
Coenzyme q. XVIII. 7,8-dimethoxy-2, 5-dimethyl-2-(4′, 8′, 12′-trimethyltridecyl)-6-chromanol (1960) (18)
Vitamin B6 deficiency in patients with a clinical syndrome including the carpal tunnel defect. Biochemical and clinical response to therapy with pyridoxine. (1976) (18)
Antagonists of LHRH superior to antide ; effective sequence/activity relationships (1990) (18)
Researches on Pyrimidines. CXXXIV. The Reaction of Phenylacetaldehyde and Acetophenone with Urea (1933) (18)
On the isolation of a prolactin inhibiting factor (hormone). (1975) (17)
Synthesis of the New 3,4-Dihydro-2-H-naphtho[1,2-b]pyran-6-yl Phosphate from Vitamin K1(20) (1963) (17)
New hydroxyquinones, apparent inhibitors of coenzyme Q enzyme systems. (1968) (17)
Synthesis of substance P analogs and agonistic and antagonistic activities. (1979) (17)
Synthesis of new alkylamino- and alkylaminomethyl-5,8-quinolinequinones as inhibitors of coenzyme Q and as antimalarials. (1972) (17)
[57] Coenzyme Q and analogs for coenzymic activity (1978) (17)
Erythrina Alkaloids. II. A Review, and new Data on the Alkaloids of Species of the Genus Erythrina* (1938) (17)
Synthesis of Degradation Products of 2-(6-Hydroxy-2-methoxy-3,4-methylenedioxyphenyl)-benzofuran (1959) (17)
Therapy with vitamin B6 with and without surgery for treatment of patients having the idiopathic carpal tunnel syndrome. (1981) (17)
Clinical Aspects of Treatment of Carpal Tunnel Syndrome with Vitamin B6 (1990) (16)
New multiprenylquinones in the biosynthesis of ubiquinone. (1967) (16)
Substance P enhances cation permeability of neuronal cell lines (1982) (16)
Partial Synthesis of Reichstein's Substance E1 (1951) (16)
New substituted 2,3-dimethoxy-1,4-benzoquinones as inhibitors of coenzyme Q systems. (1971) (16)
Tachykinins mediate changes in spinal reflexes after activation of unmyelinated muscle afferents in the rat. (1991) (16)
Enzymology of the response of the carpal tunnel syndrome to riboflavin and to combined riboflavin and pyridoxine. (1984) (16)
Exercise-limiting factors in respiratory distress. (1992) (16)
An antiovulatory decapeptide of higher potency which has an L-amino acid (Ac-Pro) in position 1. (1978) (16)
Data on structure of bovine LRH by inactivation. (1971) (16)
Identification of vitamin K2(35), an apparent cofactor of a steroidal 1-dehydrogenase of Bacillus sphaericus. (1962) (16)
Synthesis of Pyrroles and a 1,2-Dihydropyrrolo[1,2-a]pyrazin-3(4H)-one Identified as Maillard Reaction Products. (1979) (16)
Biosynthesis in vitro of the luteinizing releasing hormone by hypothalamic tissue. (1972) (16)
COENZYME Q. 53. NOVEL FINDING OF ACTIVITY FOR HEXAHYDROCOENZYME Q4 IN THE DYSTROPHIC RABBIT. (1964) (16)
Deficiency of coenzyme Q 10 in a succinate-CoQ 10 -Enzyme in the dystrophic rabbit on an antioxidant deficient diet. (1972) (16)
Notes- Coenzyme Q. XIV. Reactions of Ethyl Cyanoacetate with Dimethoxybenzoquinones (1960) (16)
EFFECT OF COENZYME Q 10 ON EXPERIMENTAL PERIODONTITIS IN DOGS (1983) (16)
Chemistry of Vitamin B6. IX. Derivatives of 5-Desoxypyridoxine (1953) (16)
Muscle fibre types, ubiquinone content and exercise capacity in hypertension and effort angina. (1991) (15)
Indirect vascular actions of (Gln4)-neurotensin in canine adipose tissue. (1978) (15)
Critical experimental parameters in gas chromatographic-mass spectrometric analysis of oligopeptide hydrolysates at the picomole level. (1977) (15)
The Trisaccharide Fraction of Some Plants Belonging to the Amaryllidaceae. (1968) (15)
The Biochemistry of Vitamin B12. (1956) (15)
Study of periodontal disease and coenzyme Q. (1975) (15)
Novel, potent luteinizing hormone-releasing hormone antagonists with improved solubility in water. (1994) (15)
RESPONSE OF MACROCYTIC ANEMIA IN CHILDREN TO THE COENZYME Q4-CHROMANOL. (1963) (15)
The elucidation of biocytin. (1951) (15)
Reduction by coenzyme Q10 of hypertension induced by deoxycorticosterone and saline in rats. (1974) (15)
Coenzyme Q. XX. Isolation of coenzymes Q9 and Q10 from two Basidiomycetes. (1960) (15)
The biological activity of DL-ubichromenol and an analogous DL-ubichromanol in vitamin E deficiencies. (1961) (15)
Antagonists of the luteinizing hormone releasing hormone (LHRH) with emphasis on the TRP7 of the salmon and chicken II LHRH's. (1984) (15)
Analogs of the luteinizing hormone-releasing hormone to study conformational aspects of the aromatic amino acid moieties and inhibition. (1974) (15)
Reduction by coenzyme Q10 of the acute toxicity of adriamycin in mice. (1977) (15)
New Benzimidazoles and Novel Use of 2-Formylbenzimidazole in Syntheses (1962) (15)
Bioenergetics in clinical medicine. III. Inhibition of coenzyme Q10-enzymes by clinically used anti-hypertensive drugs. (1975) (15)
Synthesis of vitamin b6 (1939) (15)
Isolation of ubiquinone-5, new member of ubiquinone group. (1966) (15)
Biosynthesis of the luteinizing hormone releasing hormone in mitochondrial preparations and by a possible pantetheine-template mechanism. (1973) (15)
Biocytin, a naturally-occurring complex of biotin. (1950) (14)
Apparent deficiency of vitamin B6 in typical individuals who commonly serve as normal controls. (1976) (14)
Letter: Prevention by coenzyme Q10 (NSC-140865) of the inhibition by adriamycin (NSC-123127) of coenzyme Q10 enzymes. (1976) (14)
Inhibitors of the luteinizing hormone-releasing hormone based upon modifications in the 2, 3, and 6 positions. (1976) (14)
Pronounced increase of survival of patients with cardiomyopathy when treated with coenzyme Q10 and conventional therapy. (1990) (14)
Vitamin B12. 13. Additional data on vitamin B12. (1951) (14)
Erythrina Alkaloids. VIII. Studies on the Constitution of Erythramine and Erythraline (1940) (14)
REACTIONS OF 1,2-DIMETHYLCYCLOHEXENE WITH ALKALINE HYDROGEN PEROXIDE (1979) (14)
Erythrina alkaloids. v. comparative curare-like potencies of species of the genus erythrina (1939) (14)
New quinolinequinone inhibitors of mitochondrial reductase systems and reversal by coenzyme Q. (1971) (14)
Structure Determination of Biocytin as ε-N-Biotinyl-L-lysine (1952) (14)
Potentiation of the toxicity of adriamycin by propranolol. (1978) (14)
New method for structural assignments of hydroxy analogs of coenzyme Q. (1966) (14)
Effect of adriamycin on the activity of the succinate dehydrogenase-coenzyme Q10 reductase of the rabbit myocardium. (1976) (14)
Effects of ethanol, lovastatin and coenzyme Q10 treatment on antioxidants and TBA reactive material in liver of rats. (1994) (14)
Phosphates of the Vitamin B6 Group. III. Pyridoxamine Phosphate (1951) (14)
Synthesis of Pantetheine and S-Acetylpantetheine (1954) (14)
THE PREPARATION OF DIMETHYLACETOACETIC ESTER AND OF Δ3,2,2-DIMETHYLBUTENOL-1 (1931) (14)
Erythrina Alkaloids. XIII. Studies on the Constitution of Erythraline, Erythramine, and Erythratine (1942) (14)
PITUITARY HORMONES. III.1 THE ISOLATION OF CORTICOTROPIN-B (1952) (14)
Heart failure is a dominant deficiency of coenzyme Q10 and challenges for future clinical research on CoQ10 (2004) (14)
Biotin. IV. Synthesis of 4-Benzamido-3-ketotetrahydrothiophene (1944) (14)
VITAMIN B12. XXVI. DEGRADATION OF FACTOR III TO 5-HYDROXYBENZIMIDAZOLE AND DERIVATIVES AND BIOSYNTHESIS OF FACTOR III (1955) (14)
Researches on Pyrimidines. CXLII. The Acetylation of 2-Keto-tetra- and Hexahydropyrimidines (1934) (14)
THE ACTIVITY OF A HYDROLYSATE OF ADRENOCORTICOTROPIC HORMONE IN RHEUMATOID ARTHRITIS (1950) (13)
Increased potency of antagonists of substance P having asparagine in position 6 (1989) (13)
Coenzyme Q. CIV. Structure determination of ubiquinone analogs by solvent shifts in nuclear magnetic resonance spectra (1968) (13)
NOVOBIOCIN. IV. SYNTHESIS OF DIHYDRONOVOBIOCIC ACID AND CYCLONOVOBIOCIC ACID (1956) (13)
Effects of substance P analogues on spinal dorsal horn neurons (1988) (13)
Factor C-LHIH which inhibits the luteinizing hormone from basal release and from synthetic LHRH and studies on purification of FSHRH. (1975) (13)
Erythrina alkaloids; studies on the constitution of erysodine erysovine and erysopine. (1949) (13)
Pituitary Hormones. VI. The Purification of Corticotropin-B by Countercurrent Distribution (1953) (13)
Antimetabolites of coenzyme Q. 17. Improved synthesis of 5-hydroxy-1,4-benzoquinone analogs and their indices. (1972) (13)
Biochemical evidence for a deficiency of vitamin B6 in subjects reacting to monosodium L-glutamate by the Chinese restaurant syndrome. (1981) (13)
Deficiency of coenzyme Q9 in mice having hereditary muscular dystrophy. (1970) (13)
Anticoagulant activity of a naphthoquinone analog of vitamin K and an inhibitor of coenzyme Q10- enzyme systems. (1976) (13)
Erythrina Alkaloids. XVIII. Studies on the Structure of Erysopine, Erysodine, Erysovine and Erythraline (1951) (13)
Effect of [D-Phe2, Pro3, D-Phe6]-luteinizing hormone releasing hormone, an antagonist, on preovulatory gonadotropin secretion in the rhesus monkey. (1980) (13)
Design and synthesis of antagonists of substance P. (1986) (13)
VII. Vitamin B12 and the Intrinsic Factor (1950) (13)
NITROMETHYLATION OF BENZENE USING ELECTROCHEMICALLY GENERATED MANGANESE(III) (1979) (13)
Coenzyme Q and the stability of biological membranes. (1967) (12)
Deficiency of activity of succinate dehydrogenase-coenzyme Q10 reductase in leucoytes from patiens with essential hypertension. (1974) (12)
Survey on the vitamin aspects of coenzyme Q. (1969) (12)
Preliminary Studies of the Botanical Components of Tecuna and Java Curare (1938) (12)
On the existence and separation of the follicle stimulating hormone releasing hormone from the luteinizing hormone releasing hormone. (1979) (12)
Pituitary Hormones. VII. The Nature of Corticotropin-B (1953) (12)
Ubiquinone and α-tocopherol in plasma; means of translocation or depot (2004) (12)
Vitamin B12. XXIV. DL-3,3-Dimethyl-2,5-Dioxo-4-Hydroxypyrrolidine-4-Propionic Acid Lactone and DL-3,3-Dimethyl-2,5-Dioxopyrrolidine-4-Propionic Acid, New Degradation Products (1955) (12)
Biological activities of compounds in the vitamin E, vitamin K and coenzyme Q groups in chicks, rabbits and rats. (1963) (12)
Blockade of sensory nerve mediated contraction of the rabbit iris sphincter by a series of novel tachykinin antagonists (1988) (12)
STREPTOMYCES ANTIBIOTICS. XI. THE STRUCTURE OF TETRAACETYLBISDESOXYSTREPTOBIOSAMINE (1946) (12)
Hematopoietic activity of hexahydrocoenzyme Q4 in the monkey. (1967) (12)
Sample derivatization and structure analysis by field desorption mass spectrometry. Peptide methylation-methanolysis. (1977) (12)
Specific Cleavage of O-Glycosidic Bonds to L-Serine and L-Threonine by Trifluoroacetolysis. (1979) (12)
Coenzyme Q. XLVII. New 5-Phosphomethyl-6-Chromanyl Derivatives from A Novel Reaction of Interest in Oxidative Phosphorylation (1963) (12)
The organic and biological chemistry of mevalonic acid. (1961) (12)
Pituitary Hormones. V. The Purification of Corticotropin-B by Ion-exchange Techniques (1953) (12)
Coenzyme Q. XXXVIII. Cyclization of Coenzyme Q to the Corresponding Chromenols With Sodium Hydride (1963) (12)
Streptomyces Antibiotics. XIII. The Structure of Streptobiosamine (1946) (12)
Steric Stability of Acetylenic Carotenoids. (1979) (12)
CHEMICAL STUDIES ON BRYOPHYTES. 21. FLAVONOID GLYCOSIDES OF HEDWIGIA CILIATA (1979) (12)
Decapeptides as effective agonists from L-amino acids biologically equivalent to the luteinizing hormone-releasing hormone. (1986) (12)
COENZYME Q. XXI. CONVERSION OF COENZYME Q10 INTO THE CORRESPONDING CHROMANOL (1960) (11)
A new method to determine the level of coenzyme Q10 in one drop of human blood for biomedical research. (1993) (11)
The chemistry of ubiquinone. (1966) (11)
Synthesis of di- and tripeptides and assay in vivo for activity in the thyrotropin releasing hormone and the luteinizing releasing hormone systems. (1972) (11)
Tests with lyxoflavin for vitamin activity. (1951) (11)
Identification and purification of factor B-GHRH from hypothalami which releases growth hormone. (1974) (11)
Hemostatic changes after dietary coenzyme Q10 supplementation in swine. (1996) (11)
Ubiquinone and alpha-tocopherol in plasma; means of translocation or depot. (1993) (11)
Studies on the mechanism of vitamin-like activity of coenzyme Q. (1966) (11)
Synthesis of new 2-alkylamino-1,4-naphthoquinones as inhibitors of coenzyme Q and as antimalarials. (1972) (11)
Coenzyme Q. LVI. Novel Cyclization of Quinones to Chromanols and Possible Iron-Coenzyme Q Complexes (1964) (11)
Coenzyme Q. 167. Antimetabolites of coenzyme Q. 19. Synthesis and bioassays of new dimethoxyalkylmercapto-1,4-benzoquinones (1974) (11)
Mass spectrometric characterization of pGlu-peptides related to the thyrotropin releasing hormone† (1972) (11)
Studies on Carcinolytic Compounds. IV. 6-Chloro-9-(1'-glycityl)-isoalloxazines (1952) (11)
Substance P found to lower body temperature and aggression. (1979) (11)
Synthesis and Structure of 1,5- and 1,7-Dihydro-s-indacenes. (1979) (11)
Coenzyme Q. XIX. Alkoxy Homologs of Coenzyme Q10 from Methoxy Group Exchange (1960) (11)
Coenzyme Q. XXII. chromenols corresponding to coenzyme Q10 and hexahydrocoenzyme Q4. (1960) (11)
Effect of hydroxy analogs of coenzyme Q on DPNH- and succin-oxidase activities of yeast mitochondria. (1971) (11)
Coenzyme Q deficiency in aged mice. (1978) (11)
Activity of a new synthetic tetrapeptide in hypothalamic luteinizing and follicle stimulating releasing hormone assay systems. (1971) (11)
2-Decaprenyl-6-methoxyphenol, an Apparent Biosynthetic Precursor of Ubiquinone-101 (1966) (11)
Synthesis of 2-solanesyl-1,4-naphthoquinone, new member of a vitamin K2 group. (1965) (11)
SYNTHETIC BIOTIN. (1943) (10)
Electromyographic data differentiate patients with the carpal tunnel syndrome when double blindly treated with pyridoxine and placebo. (1983) (10)
CERTAIN BENZIMIDAZOLES, BENZENES, AND RIBOFURANOSYLPURINES AS INHIBITORS OF INFLUENZA B VIRUS MULTIPLICATION (1956) (10)
Synthesis of the facteur thymique serique and an analog also related to thymopoietin (1979) (10)
Isolation of pyroglutamic acid from hypothalamic tissue and significance of its inhibition of prolactin release. (1978) (10)
The Synthesis of 2-(6-Hydroxy-2-methoxy-3,4-methylenedioxyphenyl)-benzofuran, A New Compound from Yeast (1959) (10)
Mitochondrial myopathy with anemia, cardiomyopathy, and lactic acidosis: a distinct late onset mitochondrial disorder. (1994) (10)
NOVOBIOCIN. V. THE CONFIGURATION OF THE ALDOSE MOIETY (1956) (10)
Inhibition of two human tumor cell lines by antimetabolites of coenzyme Q10. (1978) (10)
Study of a possible structural relationship between thymopoietin and the facteur thymique serique. (1978) (10)
Specificity of Design to Achieve Antagonists of LHRH of Increasing Effectiveness in Therapeutic Activity (1987) (10)
Studies of inhibition of the luteinizing hormone-releasing hormone by an irreversible inhibitor at the receptor site. (1974) (10)
Isolation of N-acetylaspartic acid from hypothalamic tissue and significance of its ACTH-releasing activity. (1978) (10)
Vitamin B12. XII. Vitamin B12-like Activity of α- and β-Ribazole (1951) (10)
Vitamin B12. XIX. Synthesis of the 1-D-Ribosides of 5,6-Dimethylbenzimidazole (1952) (10)
Growth Factors for Polyporus Schweinitzii. The Identification of Ferulic Acid as a New Cofactor (1963) (10)
Perspectives from research on vitamins and hormones (1984) (10)
Synthesis and biological activities of neurokinin α and β (1984) (9)
A modified determination of coenzyme Q10 in human blood and CoQ10 blood levels in diverse patients with allergies. (1988) (9)
Synthesis of rhodoquinone and other multiprenyl-1,4-benzoquinones biosynthetically related to ubiquinone. (1968) (9)
Notes - Identity of Mevalonic and Hiochic Acids (1958) (9)
Synthesis of the New 5-Phosphomethyl-6-chromanyl Acetate of Vitamin K1(20) by a Novel Cyclization Reaction (1963) (9)
Effect of coenzyme Q on serum levels of creatine phosphokinase in preclinical muscular dystrophy. (1974) (9)
Studies on analogs of the luteinizing releasing hormone towards elucidation of the release mechanism. (1972) (9)
Occurrence of ubiquinones-8 and -9 in Plasmodium lophurae. (1967) (9)
Synthesis of peptides related to substance p and their activities as agonists and antagonists (1979) (9)
Reactions of Cyclopentadienyl(tributylphosphine)copper(I) and Nickelocene with Some alpha-Bromo Acids. (1979) (9)
INHIBITION OF INFLUENZA VIRUS MULTIPLICATION BY ALKYL DERIVATIVES OF BENZIMIDAZOLE (1953) (9)
Amides and Amino Acid Derivatives of Biotin (1951) (9)
Researches on Pyrimidines. CXXXI. The Reduction of 1,2,3,4-Tetrahydropyrimidines (1933) (9)
The carpal tunnel syndrome as a probable primary deficiency of vitamin B6 rather than a deficiency of a dependency state. (1980) (9)
On the structure of the hypothalamic luteinizing releasing hormone. Evidence for the presence of arginine, tyrosine, and tryptophan by inactivation. (1971) (9)
Mechanisms Involved in Release of Thyroid Stimulating Hormone (TSH) and Other Pituitary Hormones (1975) (9)
Studies related to vitamin B13. (1958) (9)
Research on Vitamin B: The story of vitamin B is not complete; it has just started to unfold . . . (1950) (9)
COENZYME Q. XLIX. CHARACTERIZATION OF COENZYME Q10(H-10) FROM PENICILLIUM STIPITATUM. (1963) (9)
VITAMIN B12. XXVII. STRUCTURE OF THE FACTOR III NUCLEOSIDE AND SYNTHESIS OF HYDROXY- AND METHOXYBENZIMIDAZOLE RIBOSIDES (1956) (9)
Rotational Barriers and Dimer Association of Simple Polymethine Dyes. (1979) (9)
Relationships between coenzyme Q and vitamin E (1974) (8)
Metabolic stability of the LHRH antagonist antide to cell-surface peptidases. (1991) (8)
Stimulation of lymphocyte proliferation to monitor fractionation of thymus extracts. (1982) (8)
The Purification of Subtilin Concentrates by Counter-current Distribution (1951) (8)
VITAMIN B12. XXI. CRYSTALLINE α-RIBAZOLE PHOSPHATE AND ITS SYNTHESIS (1952) (8)
Dependence of Equilibrium Geometry and Rearrangement Modes on Electron Count in One Class of Trinuclear Complexes of Acetylene. (1979) (8)
CATALYSIS BY ALUMINA AND ZINC OXIDE OF THE DISPROPORTIONATION OF CERTAIN ALCOHOLS, ETHERS AND HYDROXY ESTERS (1931) (8)
The biochemistry of vitamin B6 is basic to the cause of the Chinese restaurant syndrome. (1984) (8)
Significance of biological parameters of human blood levels of CoQ10. (1988) (8)
A new category of ovulation inhibitors: linear LH-RH analogues having more than ten residues. (1979) (8)
Progress in biomedical and clinical research on coenzyme Q10 (1984) (8)
Pharmacological assessment of spantide II analogues. (1994) (8)
RATES OF DISSOCIATION OF PYRIDOXAL 5’-PHOSPHATE FROM GLUTAMIC OXALOACETIC TRANSAMINASE IN A NORMAL AND DEFICIENT STATE (1981) (8)
Preparation of uniformly 14c-labeled p-hydroxybenzoic acid (1973) (8)
Therapy of hereditary mouse muscular dystrophy with coenzyme Q7. (1970) (8)
Friedel-Crafts Reactions. III. Electrophilic Amidoalkylation of 1,3,5-Trimethoxybenzene with Cyclic N-Formylimmonium Ion Precursors. (1979) (8)
Synthesis of 2,5-H-2,5-azepindiones from quinones and hydrazoic acid (1966) (8)
Discovery and chemistry of mevalonic acid. (1961) (8)
Therapy with Coenzyme Q10 for Patients with Periodontal Disease. 2. Effect of Coenzyme Q10 on the Immune System. (1993) (8)
Antagonists of substance P from emphasis on position 11. (1983) (8)
Deuterium Labelling of Tryptamine, Serotonin and their N-Methylated Metabolites Using Solvent Exchange Reactions. (1979) (7)
SMALL-SCALE PREPARATIVE SEPARATION OF (-)-MENTHONE AND (+)-ISOMENTHONE BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (1979) (7)
Stability of Glutamic Acid, Glutamine, and gamma-Glutamyl Derivatives during Isolation from Natural Sources. (1979) (7)
Erythrina Alkaloids. XII. Chromatographic Analyses of Erysodine, Erysovine and “Erysocine” and Technique for Preparative Isolation1 (1942) (7)
Erythrina Alkaloids. VI. Studies on the Constitution of Erythramine (1939) (7)
The Enzymic Reductions of Aryl-aldehydes and Aryl-alcohols in Penicillium baarnense. (1979) (7)
Antiovulatory Potency and Conformation of an Antagonist of the Luteinizing Hormone-Releasing Hormone Having Six D-Amino Acids (1982) (7)
Prevention by coenzyme Q10 of the electrocardiographic changes induced by adriamycin in rats. (1979) (7)
RELATIONSHIP BETWEEN STRUCTURE OF BENZIMIDAZOLE DERIVATIVES AND SELECTIVE VIRUS INHIBITORY ACTIVITY (1961) (7)
N-Phenylacetyl-L-cysteinyl-D-valine (1952) (7)
The reaction of pyridinecarboxylic acids with dicyclohexylcarbodiimide and p-nitrophenol. (1988) (7)
The Preparation of Active, Non-antidiuretic Hydrolyzates of ACTH (1952) (7)
Two sites of coenzyme Q in mitochondria of Saccharomyces cerevisiae. (1969) (7)
Relationships between coenzyme Q and vitamin E. (1974) (7)
Coenzyme Q.XXVIII.Activity of the coenzyme Q group in sperm motility. (1961) (7)
Biotin l-Sulfoxide. II. The Isolation of a Crystalline Factor with Biotin Activity from Aspergillus niger Culture Filtrates (1954) (7)
The new synthetic 6-chromanyl phosphate of vitamin K1(20) and its behavior in an enzymatic system from Mycobacterium phlei. (1962) (7)
Pituitary Hormones. IV. The Preparation of Potent Concentrates of Corticotropin and Corticotropin-B (1953) (7)
Vitamin B12. XXIII. Resolution of DL-1-Amino-2-propanol (1954) (7)
Studies on the follicle stimulating hormone releasing hormone by radioimmunoassays and by bioassays. (1980) (7)
New, highly active antagonists of LHRH with acylated lysine and p-aminophenylalanine in positions 5 and 6. (2009) (7)
Structural requirements in positions 1, 2, 3, and 6 of the luteinizing hormone-releasing hormone (LH-RH) for antiovulatory activity. (1979) (7)
Synthesis of plastoquinone analogs and inhibition of photosynthetic and mammalian enzyme systems. (1972) (7)
Vitamin B12. XVIII. The Degradation of Vitamin B12 to 1-α-D-Ribofuranosyl-5,6-dimethylbenzimidazole (1952) (7)
ELECTROCHEMICAL REDUCTION OF SOME PYRIMIDINE DERIVATIVES (1980) (7)
Human deficiencies of vitamin B6. I. Studies on parameters of the assay of the glutamic oxaloacetic transaminase by the CAS principle. (1975) (7)
Synthesis, enzyme inhibition, and antitumor activity of new 1,4-benzoquinone analogs of coenzyme Q10☆ (1978) (7)
COENZYME Q. LVII. SYNTHESIS OF NEW ANALOGS OF COENZYME Q-4 FOR BIOCHEMICAL MECHANISM STUDIES. (1964) (6)
On the importance of position one of ovulation inhibitors, as based on studies on [D-Phe2, Pro3, D-Phe6]-LHRH. (1977) (6)
Survey and new clinical studies on conenzyme Q in human muscular dystrophy. (1972) (6)
SRS-S concentrates from normal swine lung without anaphylaxis. (1961) (6)
Synthesis of DL-Dimethyldihydro-α-lipoic Acid (1955) (6)
Acidic analogs of the luteinizing hormone-releasing hormone and conformational aspects for activity. (1974) (6)
Antimetabolites of coenzyme Q. XV. Inhibition of mitochondrial reductase systems by naphthoquinone and quinolinequinone analogs. (1973) (6)
Vitamin activity of coenzyme Q in nutritionally deficient hamsters as evident from effect on proteolytic and autolytic enzymes. (1972) (6)
Hydrogenolysis of β-Oxygenated Esters to Glycols (1948) (6)
The impact of natural product chemistry on medicine (1967) (6)
Bioenergetics in clinical medicine XIV. Studies on an apparent deficiency of coenzyme Q-10 in patients with cardiovascular and related diseases. (1978) (6)
Antimetabolites of coenzyme Q and their potential clinical use as antitumor agents: A new biochemical approach to cancer chemotherapy (1984) (6)
Vitamin B12. XX. Synthesis of 1-Glycosides of 5,6-Dimethylbenzimidazole (1954) (6)
Explosion Hazard in the Chlorination of Alkyl Isothioureas to Prepare Alkyl Sulfonyl Chlorides (1941) (6)
Could coenzyme Q10 affect hemostasis by inhibiting platelet vitronectin (CD51/CD61) receptor? (1997) (6)
Biosynthesis and levels of coenzyme Q in genetically dystrophic mice. (1968) (6)
XVIII. The Penilloic and Penicilloic Acids and Their Derivatives and Analogs (1949) (6)
Synthesis of lyxoflavin. (1951) (6)
Antimetabolites of coenzyme Q. 20. Synthesis of new alkyl-5,8-quinoxalinequinones as potential inhibitors of coenzyme Q and as antimalarial drugs. (1973) (6)
Isolation of Tomatidine from the Roots of the Rutgers Tomato Plant (1951) (6)
Solid Phase Synthesis of Thymopoietin-(32-36) Using Adpoc Amino Acids and its Biological Activity + (1980) (5)
Bioenergetics in clinical medicine-X. Survey of the adjunctive use of coenzyme Q with oral therapy in treating periodontal disease. (1977) (5)
Isolation, partial chemical and biological characterization of thymone B. (1980) (5)
Spantide III, a superior tachykinin antagonist with high potency and negligible neurotoxicity (1993) (5)
Differentiation of factor C-LHIH and the synthetic contraceptive polypeptide, H-Thr-Pro-Arg-Lys-OH. (1975) (5)
Isolation of thymone A from bovine thymus partial chemical and biological characterization. (1980) (5)
Some aspects of streptomycin and other streptomyces antibiotics. (1950) (5)
Ischaemic heart disease, skeletal muscle fibres and exercise capacity. (1992) (5)
Synthesis of 31- and 35-amino acid carboxyl terminal fragments of the beta subunit of the human chorionic gonadotropin. (1977) (5)
C-Alkylation of Pyrimidines by an Oxoalkyl Reactant. (1979) (5)
Acylation of Enamines. Regiospecific Transformation of Unsymmetrical Methyl Ketones to 1,3-Diketones via Benzoylation of Enamines. (1979) (5)
Coenzyme Q, XXIX. Monophosphate of dihydrocoenzyme Q10. (1961) (5)
Distribution of vitamin B6 deficiency in university students. (1981) (5)
Neurotensin and its amide analogue [Gln4]-neurotensin: effects on brain monoamine turnover (1978) (5)
Chemistry of Vitamin B6. X. Some Homologs of the Vitamin B6 Group (1953) (5)
Apparent low levels of ubiquinone in rat and human neoplastic tissues. (1968) (5)
New procedures for assay and stability of coenzyme Q10 in human blood. (1968) (5)
Coenzyme Q deficiency in mice following infection with Friend leukemia virus. (1975) (5)
Vitamin B 12 , A Cobalt Complex (1948) (5)
A modified E-rosette assay as a semi-empirical tool in search of new T lymphocyte stimulants. (1991) (5)
Vitamin B12. XXV. 3,3-Dimethyl-2,5-dioxopyrrolidine-4-propionamide: A New Degradation Product (1955) (5)
A superior analysis of coenzyme Q10 in blood of humans, rabbits and rats for research. (1988) (5)
Relative Potencies of Antagonists of the Luteinizing Hormone Releasing Hormone with Lys8 and Arg8 and Substitutions in Positions 3 ,5 ,6 ,7 and 8 (1986) (5)
Synthesis of 2,5-2,5-azepindiones by the reaction of quinones with hydrazoic acid (1965) (5)
Inhibition of the activity of the luteinizing hormone-releasing hormone (LH-RH) by analogues with variations at positions 2, 3, and 6 and the carboxyl terminus. (1977) (5)
Vitamin B12. XXII. Relation of α-Ribazole Phosphate to Vitamin B12 (1953) (5)
Isolation of glutathione from bovine thymus and its significance to research relevant to immune systems. (1980) (5)
ON THE SIGNIFICANCE OF BIOLOGICAL ACTIVITIES IN THE COENZYME Q AND VITAMIN E GROUPS. (1965) (5)
Activities of Antagonists of the Luteinizing Hormone Releasing Hormone with Emphasis on Positions 1, 5 and 6 and on Positions 1, 2 and 3 (1987) (5)
On the synthesis of pantothenic acid and derivatives. (1941) (5)
The Crystal Structure of Methoxycarbonylcholine Iodide, an Acetylcholine Analogue with Extended Conformation. (1979) (5)
(Gln4)-neurotensin inhibits the interdigestive migrating motor complex in man (1980) (5)
Effect of synthetic substance P on monoaminergic mechanisms in brain (2005) (5)
Hydrogenation and Hydrogenolysis of a 2-Keto-1,2,3,4-tetrahydropyrimidine Derivative to 2-Benzyl- and 2-Hexahydrobenzylbutanol-11 (1936) (4)
Synthesis and inhibitory activity of new ethylenedioxyquinones as analogs of coenzyme Q. (1973) (4)
Coenzyme Q10 and key enzyme activities in papillary muscle related to left ventricle function in mitral valve disease (1988) (4)
Erythrina alkaloids; a colorimetric determination of beta-erythroidine. (1946) (4)
8-Hydroxy-2-keto-5-methoxy-4a-methyl-2,3,4,4a,9,10- hexahydrophenanthrene (1955) (4)
New 2-methyl-6-alkylamino-5,8-quinolinequinones and 1,2,3,4-tetrahydro derivatives† (1974) (4)
Study of the combined and separate administration of doxorubicin and coenzyme Q10 on mouse cardiac enzymes. (1979) (4)
Comparative Data on Vitamin B 12 From Liver and From a New Source, Streptomyces griseus (1948) (4)
Antagonists of LHRH with Histidine in the Priority Position 8 (1993) (4)
Nucleophilic Reactions of o-Halomethylbenzylidenemalonates, Cyano Esters and Malonitriles. (1979) (4)
Nonapeptide ethylamide inhibitors of the luteinizing hormone-releasing hormone (LH-RH) having a D-alanyl residue in position 6 and variations at positions 2 and 3. (1977) (4)
Deficiency of vitamin B6 in women taking contraceptive formulations. (1977) (4)
A new enzymic assay for human deficiencies of coenzyme Q10. (1973) (4)
Notes - 3-Isoxazolidone (1957) (4)
Inhibition of nucleic acid synthesis in leukemia 1210 cells by antimetabolites of coenzyme Q10. (1978) (4)
Design, Synthesis and Biological Evaluation of Antagonists of LHRH by Criteria of Potency, Safety and Solubility (1991) (4)
Coenzyme Q. IV. Coenzyme Activity of 6-Isoprenoid and Other Derivatives of 2,3-Dimethoxy-5-Methylbenzoquinone (1959) (4)
Hypothalamic hormones. 71. Synthesis and some biological activities of the tyrosine-8 analog of substance P (1976) (4)
The 6-chromanyl acetate of vitamin K-1(20). (1962) (4)
Analogs of the Luteinizing Hormone Releasing Hormone having the Azagly10 Moiety with Antiovulatory Activity (1984) (4)
Inhibition of Mycobacterium intracellulare by some vitamin K and coenzyme Q analogues. (1978) (4)
Biomedical and clinical aspects of coenzyme Q. Proceedings of the International Symposium on Coenzyme Q, held at Lake Yamanaka, Japan, September 16/17, 1976, a Naito Foundation Symposium. (1977) (4)
Hydrogenolysis of aromatic esters to alcohols. (1948) (4)
Determination of releasing hormones in subcellular fractions from porcine hypothalamic tissue. (1973) (4)
Structure determination of ubiquinone analogs by solvent shifts in nuclear magnetic resonance spectra. (1968) (4)
Considerations of Veristic and Quasi-biological Activities for Coenzyme Q and Vitamins E and K (2015) (4)
Hematological activity of coenzyme Q in an anemia of human malnutrition. (1968) (4)
Deficiency of coenzyme Q10 in the rabbit. (1969) (4)
Family planning and other population controls. (1968) (4)
Lipoprotein Models: Ultrasonicated Emulsions of Phosphatidylcholine, Cholesterol and Triolein. (1979) (4)
INTRAVENOUS USE (2017) (4)
Vitamin Activity of Lyxoflavin (1951) (4)
SYNTHESIS OF ALKYL-4,7-DIOXOBENZOTHIAZOLES WITH PROPHYLACTIC ANTIMALARIAL ACTIVITY (1974) (4)
Superiority of an antagonist of the luteinizing hormone releasing hormone with emphasis on arginine in position 8, named Argtide. (1991) (4)
OZONIZATION OF ALLENIC ESTERS (1979) (4)
COENZYME Q IN DUCHENNE MUSCULAR DYSTROPHY (1971) (4)
Erythrina Alkaloids. XVII. Tetrahydroerysovine (1950) (4)
A synthetic peptide capable of eliciting antibodies that neutralize human chorionic gonadotropin. (1981) (3)
The toxicity of tetrahydrobiopterin: acute and subchronic studies in mice. (1986) (3)
Coenzyme Q. LX. Vitamin-Like Activity of Coenzyme Q.∗ (1965) (3)
Reduced-size antagonists of luteinizing hormone-releasing hormone active in vitro. (1995) (3)
The finding and partial purification and characterization of thymone C. (1981) (3)
Response of mice with genetic dystrophy to therapy with coenzyme Q. (1968) (3)
BIOTIN. III. cis and trans FORMS RELATED TO dl-BIOTIN (1944) (3)
Synthesis and bioassays of a new dimethoxyalkylmercapto-1,4-benzoquinones. (1974) (3)
VII. Review of Certain Investigations on the Structure of Benzylpenicillin during 1944-1945 (1949) (3)
ANALOGS OF THE LUTEINIZING HORMONE-RELEASING HORMONE TO STUDY CONFORMATIONAL ASPECTS OF THE AMINO ACID MOIETIES AND INHIBITION (1974) (3)
Carcinolytic Compounds. III. 9-(1'-Glycityl)-isoalloxazines (1952) (3)
Streptomyces antibiotics; conversion of streptamine into streptidine. (1948) (3)
Vitamin B 12 : The Identification of Vitamin B 12 as a Cyano-Cobalt Coordination Complex (1950) (3)
Anodic Synthesis of Fluorinated Quinones. (1979) (3)
PEPTIDE HORMONES. 109. INHIBITORY ANALOGS OF THE LUTEINIZING HORMONE-RELEASING HORMONE HAVING D-AROMATIC RESIDUES IN POSITIONS 2 AND 6 AND VARIATION IN POSITION 3 (1978) (3)
The chemistry of vitamin B6; pyridoxylamino acids. (1948) (3)
Synthesis of coenzyme Q analogs by alkylation of fumigatin. (1966) (3)
Inhibition of preovulatory gonadotropin secretion in the rhesus monkey by [( (1980) (3)
Chemistry and Biosynthesis of the Hypothalamic Releasing and Inhibiting Neurohormones (1973) (3)
Activities of LHRH antagonists in rhesus monkeys during the periovulatory interval of the menstrual cycle and early pregnancy. (1981) (3)
The Preparation of Pure Apocodeine and its Hydrochloride (1936) (3)
Urinary excretion of coenzyme Q10 by patients with diabetes mellitus. (1961) (3)
The vitamin activity of coenzyme Q 7 in reproduction in the rat. (1971) (3)
Mass spectrometry of ubiquinones. Thermal loss of a methoxyl group (1968) (3)
Streptomyces Antibiotics. XVII. Heptabenzoylstreptidine from Streptomycin (1948) (3)
Studies on Carcinolytic Compounds. VI. Substituted 2-(Aldo-Polyhydroxyalkyl)-benzimidazoles (1956) (3)
Substance P: structural requirements for the activation of brain catecholamine synthesis and locomotor activity in rats. (1983) (3)
Clinical studies with coenzyme Q10 in patients with congestive heart failure (1984) (3)
Condensation Reactions of Acetaldehyde over Certain Oxide Catalysts at Pressures from 1 to 500 Atmospheres of Hydrogen (1930) (3)
Studies on the basal specific activity of the glutamic oxaloacetic transaminase of erythrocytes in relationship to a deficiency of vitamin B6. (1977) (3)
Synthetic Peptides that Release TSH and LH from the Pituitary (1972) (3)
Research on Coenzyme Q (1967) (3)
N-Quaternary Compounds. Part LIV. Isomerization by Flash Vacuum Pyrolysis. (1979) (3)
Heterogeneously Catalysed Alkylations of Indole and 2,3-Dihydroindole. (1979) (3)
Presence of peptide hormones that control gonadotropin secretion in extrahypothalamic areas of the brain. (1977) (3)
Vitamin activity of coenzyme Q as revealed by normalization of elevated proteolytic and autolytic enzymes in skeletal muscle of antioxidant deficient rats. (1973) (2)
Sulfonation of 2- and 3-Methylphenol. (1979) (2)
Vitamin activity of coenzyme Q in chickens and turkeys. (1969) (2)
Synthesis and Antiovulatory Activities in Rats of Analogs of the Luteinizing Hormone Releasing Hormone Having a Moiety of /?-(3-Quinolyl)-D-a-alanine in Positions 3 and 6 (1983) (2)
The effect of ethanol and/or food restriction on coenzyme Q in liver in rats. (1997) (2)
Therapeutic activity of coenzyme Q for reproduction. (1968) (2)
Advantages of ferric ferricyanide to detect certain peptides and proteins on chromatograms. (1982) (2)
Response of the bone marrow of the vitamin E-deficient rabbit to coenzyme Q and vitamin E. (2009) (2)
Chemistry of Vitamin B6. XI. Homologs of 4-Desoxypyridoxine (1953) (2)
Determination of Structure of β,δ-Dihydroxy-β-methylvaleric Acid (2009) (2)
Synthesis and biological activities of neurokinin alpha and beta. (1984) (2)
A Glutaconaldehyde Enol Ester with cis Configuration. (1979) (2)
An Enzymatic Synthesis of sym-Bis-(N-carbobenzoxy-L-alanyl)-hydrazine (1951) (2)
[Usefulness of coenzyme Q10 in the treatment of hypertension]. (1981) (2)
Biochemistry of Quinones. (1966) (2)
IX. Desthiobenzylpenicillin and Other Hydrogenolysis Products of Benzylpenicillin (1949) (2)
Long-term administration of a substance P antagonist, (D-Pro2, D-Trp7,9)-SP, abolishes the response to ocular trauma (1984) (2)
On the Electrochemical Reduction of Benzo-1,2,3-triazin-4(3H)-ones. (1979) (2)
Coenzyme Q. XLIII. The new 5-chloromethyl-6-chromanyl acetate of vitamin K-1(20). (1963) (2)
THE REACTIONS OF ACETALDEHYDE OVER ZINC CHROMITE UNDER A PRESSURE OF 210 ATMOSPHERES (1931) (2)
Coenzyme Q. XXXII. Coenzyme Q and the maintenance of sperm cells in Vitro (1963) (2)
A Structure and Conformation Study of DL-threo-3,4-Dihydroxyphenylserine and its Hydrochloride Trihydrate. (1979) (2)
Coenzyme Q. XXXIX. Studies on the biosynthesis of coenzyme Q10 (1963) (2)
A critique on analog antagonists of LHRH. (1981) (2)
Erythrina Alkaloids. XIX. Studies on the Structure of β-Erythroidine (1950) (2)
Nitrogen-substituted Chloroalkylamines1 (1948) (2)
Synthesis and bioassay of LHRH-antagonists with N-Ac-D-O-phenyltyrosine and N-Ac-D-3-(2-dibenzofuranyl)alanine in position 1. (2009) (2)
[223] Assay of coenzyme Q10 in blood (1971) (2)
Coenzyme O in Duchenne muscular dystrophy. A preliminary therapeutic trial. (1971) (2)
Synthesis and Bioassay of Antagonists of the Luteinizing Hormone Releasing Hormone Having the Azagly10 Moiety (1982) (2)
Amino acids, peptides, and proteins (1960) (2)
Critique of 30 Years of Research on Hematopoietic and Immunological Activities of Coenzyme Q10 and Potentiality for Therapy of AIDS and Cancer (1992) (2)
Levels of the glutamic oxaloacetic transaminase of erythrocytes of pregnant women and of cord bloods of newborn infants. (1978) (2)
Tabulation of findings in the muscular dystrophies and in myotonia dystrophica. (1971) (2)
A Critique of 25 Years of Research Which Culminated in the Successful Therapy of Periodontal Disease with Coenzyme Q10 (1992) (2)
Isolation and Partial Characterization of Adipotropin, an Apparent New Lipolytic Peptide from Bovine Anterior Pituitary Lobes (1980) (2)
Improved synthesis and resolution of β-(3-pyridyl)-DL-α-alanine (2009) (2)
Identification and purification of factor A-GHRH from hypothalami which releases growth hormone. (1974) (2)
The finding and significance of spermidine and spermine in Fraction 5. (1982) (2)
Study of Hydrogenolytic Cleavage of Peptide-Resin Benzyl Ester Bonds for Synthesis of Protected Fragments of the Human Leukocyte Interferon (1983) (2)
Response of the nutritionally dystrophic rabbit to therapy with the coenzyme Q group. (1968) (2)
New alkylmercapto-2,3-dimethoxy-1,4-benzoquinones as inhibitors of coenzyme Q systems. (1977) (2)
The Preparation of Thiophenes and Tetrahydrothiophenes (2011) (2)
Biosynthesis of coenzyme Q10 from p-hydroxybenzoic acid in beating heart cell cultures. (1970) (2)
Session 2: Summary and Prospects (1967) (1)
Physiological evidence for the identity of pyro glutamine histidine proline amine and porcine thyrotropin releasing hormone (1970) (1)
Identification of crystalline vitamin B12a. (1949) (1)
Synthesis of [Gln4]-neurotensin using a new solid support, the 4-(hydroxymethyl)phenylacetamidomethyl-resin (1979) (1)
The structural features of effective antagonists of the luteinizing hormone releasing hormone (1994) (1)
Carcinolytic Compounds. II. 1-(1'-Glycityl)-benzimidazoles (1951) (1)
CHLORINATED POLYCYCLIC COMPOUNDS. IX. ALKALINE CLEAVAGE OF CHLOROSUBSTITUTED DIBENZOBICYCLO(2.2.2)OCTADIEN-7-ONES (1979) (1)
Chapter VIII - Vitamin B12 (1963) (1)
Synthesis and coenzymatic activity of ubiquinone-12. (1968) (1)
Snythesis of analogs of the thyrotropin releasing hormone (TRH) and bioassays for TRH- and TRH-inhibiting activities. (1973) (1)
Substance P antagonist inhibits capsaicin-induced smooth muscle contractions (1983) (1)
Fragment couplings with stepwise couplings in solid-phase synthesis. Synthesis of a fragment of human leukocyte interferon. (1984) (1)
Parameters in determining the specific activity of the succinate dehydrogenase-coenzyme Q10 reductase in mitochondria of leucocytes. (1974) (1)
Vitamin deficiencies and perspectives on coenzyme Q. (1967) (1)
Effective antagonists of luteinizing hormone releasing hormone modified at position one (1993) (1)
Vitamin B 12 : Reactions of Cyano-Cobalamin and Related Compounds (1950) (1)
Evolution of Design and Achievement of Inhibitors of the Luteinizing Hormone-Releasing Hormone as Inhibitors of Ovulation (1982) (1)
Electron Deficient Heteroaromatic Ammonioamidates. XVII. N-(3-Quinazolinio)amidates. VI. The Photochemistry of N-(3-quinazolinio)amidates in the Presence of alpha-Toluenethiol. (1979) (1)
Discovery and Elucidation of Mevalonic Acid (2009) (1)
Biosynthesis of ubiquinone-10 from p-hydroxybenzoic acid by leucocytes of the human and rhesus monkey. (1970) (1)
Introductory remarks. Historical perspectives on the isolation of crystalline vitamin B12 (1979) (1)
Absence of coenzyme Q10 as an intrinsic component of aldehyde oxidase. (1974) (1)
Structurally restricted conjugates of the beta-subunit of the human chorionic gonadotropin to produce antisera. (1983) (1)
Antagonists of the Luteinizing Hormone Releasing Hormone with Emphasis on Amino Acids in Position Five (1985) (1)
The Crystal and Molecular Structure of 1-(beta-Aminoethyl)-4-hydroxy-5-iodo-3,6-benzoquinone, an Oxidation Product of 6-Hydroxydopamine. (1979) (1)
Coenzyme Q. XXIII. Organic and Biological Studies (2008) (1)
Coenzyme Q and analogs for coenzymic activity. (1978) (1)
Stimulation of coleoptile elongation in Zea mays by p-hydroxybenzoic acid. (1975) (1)
The Reaction of Pyridinecarboxylic Acids with Dicyclohexylcarbodiimide and p‐Nitrophenol. (1988) (1)
An epoxyubiquinone-10 related to beef heart mitochondria and its significance in nutrition. (1969) (1)
THE CRYSTAL AND MOLECULAR STRUCTURE OF 7-IODOADRENOCHROME (1979) (1)
Hexahydrocoenzyme Q 4 in pseudohypertrophic muscular dystrophy. (1971) (1)
An X-Ray and Vapour Pressure Study of the Monoolein-Cholesterol-Water System. (1979) (1)
Study of activities of the succinate dehydrogenase-coenzyme Q reductase in leucocytes of patients with controlled hypertension. (1978) (1)
IV. Status of the Research on the Structure of Benzylpenicillin in December 1943 (1949) (1)
Studies on the Follicle-Stimulating Hormone-Releasing Hormone and on Prohypothalamic Hormones1 (1980) (1)
The Finding and Significance of Spermidine and Spermine in Thymic Tissue and Extracts (1984) (1)
Erythrina Alkaloids. XX. Apo- and Isoapo-β-erythroidine (1951) (1)
Research On Thymic Peptides And Immunocompetence (1981) (1)
Antide B, an antagonist of LHRH with cis-3-(4-pyrazinylcarbonylaminocyclohexyl)alanine in position 5 (1995) (1)
Proceedings of the fifth International Symposium on the Biomedical and Clinical Aspects of Coenzyme Q, held in Tokyo, Japan, 24-26 October 1985 (1986) (1)
Improved synthesis and resolution of beta-(3-pyridyl)-DL-alpha-alanine. (1984) (1)
On the protection against infarction by corn oil. (1968) (1)
Dietary vitamin B-6 in college students (1985) (0)
BLOOD PLASMA OR BLOOD SERUM OTHER PUBLICATIONS (2016) (0)
Proceedings of the Second International Symposium on Coenzyme Q, held in Tokyo, Japan, September 29-30, 1979, a Naito Foundation Symposium (1980) (0)
DESIGN AND SYNTHESIS OF EFFECTIVE ANTAGONISTS OF SUBSTANCE P (1982) (0)
N5-Pyrazinylcarbonylornithine, an Effective Substituent for Position 5 of Antagonists of LHRH (1995) (0)
Biotin. 6. Resolution of dl-biotin. (1945) (0)
SYNTHESIS OF 31- AND 35-AMINO ACID CARBOXYL TERMINAL FRAGMENTS OF THE β SUBUNIT OF THE HUMAN CHORIONIC GONADOTROPIN (1978) (0)
FRAGMENT COUPLINGS WITH STEPWISE COUPLINGS IN SOLID-PHASE SYNTHESIS. SYNTHESIS OF A FRAGMENT OF HUMAN LEUKOCYTE INTERFERON (1984) (0)
[Coenzyme Q. LIX. Photochemical cyclization of coenzyme Q to D,L-chromenol]. (1965) (0)
(54) PEPTIDE ANTAGONISTS OF SUBSTANCEP (2017) (0)
Synthesis of new 2,5-bis (1-alkylamino)-1,4-benzoquinones toward antimetabolites of coenzyme Q10 and antitumor agents. (1979) (0)
Anti ovulatory Activity of a Potent LH-RH Antagonistic Analogue ( NAcD-Trp . 3 , D-pCl-Phe , D-Phe 6 , DAlal . 0 ) LH-RH ( ALH-RH ) (2017) (0)
Hormone Bind to Rat Mast Cells and Induce Histamine Release , ” Agents and Actions , 25 ( 3 / 4 ) : 307-313 , 1988 , published in Europe (2017) (0)
A process for preparing chromanols (1965) (0)
NONAPEPTIDE ETHYLAMIDE INHIBITORS OF THE LUTEINIZING HORMONE‐RELEASING HORMONE (LH‐RH) HAVING A D‐ALANYL RESIDUE IN POSITION 6 AND VARIATIONS AT POSITIONS 2 AND 3 (1978) (0)
Chromenylverbindung and processes for their preparation (1963) (0)
Biological evidence that separate hypothalamic hormones release the follicle stimulating and lutneinizing hormones. (1973) (0)
National Academy of Sciences. Biographical Memoirs, VOLUME 81 PUBLISHED 2002 BY THE NATIONAL ACADEMY PRESS (0)
N5‐ピラジニルカルボニルオルニチン,LHRHのきっ抗薬の5位に対する有効な置換基 (1995) (0)
A pioneer synthesis of conjugates of a thymic peptide hormone and polyamines. (1984) (0)
Studies on vitamin B12 and ubiquinone (1979) (0)
Peripheral and central nervous actions of substance P antagonists. (1982) (0)
V – Specificity of Action (1954) (0)
INTRODUCTORY REMARKS (1960) (0)
ANTIMETABOLITES OF COENZYME Q PART 20, SYNTHESIS OF NEW ALKYL-5,8-QUINOXALINEQUINONES AS POTENTIAL INHIBITORS OF COENZYME Q AND AS ANTIMALARIAL DRUGS (1974) (0)
CHLORINATED POLYCYCLIC COMPOUNDS. VIII. A NEW APPROACH TO 2-FUNCTIONALIZED 3,6-DIBENZOBICYCLO(3.3.0)OCTADIENE DERIVATIVES (1979) (0)
Nitrogen-substituted chloroalkylamines. (1948) (0)
Effective hormonal peptides: D-3-Pal.sup.6 -LHRH (1987) (0)
INHIBITION OF RESPIRATORY FUNCTION OF HEART MUSCLE MITOCHONDRIA BY PSYCHOTROPIC AGENTS AND PREVENTION BY COENZYME Q (1980) (0)
LHRH antagonist with negligible histamine releasing activity, which is a decapeptide and the use of the decapeptide (1990) (0)
Synthesis of a Combined Fragment of Interferon, AcHuIFN αA(30-43)-(123-137)-NH2. Interferon May not be a Sychnological Peptide (1983) (0)
Design, synthesis and biological evaluation of antagonists of LHRH including substitutions with L-azetidine 2-2-carboxylic acid (1992) (0)
SOLID PHASE SYNTHESIS OF THYMOPOIETIN-(32-36) USING ADPOC AMINO ACIDS AND ITS BIOLOGICAL ACTIVITY (1981) (0)
Additions and Corrections: Coenzyme Q. XI. The Structure of Solanesol. (1959) (0)
Process for the preparation of a progestin-releasing hormone antagonistidekapeptidin (1990) (0)
DISCOVERYOF A NEW ACETATE-REPLACINGFACTOR1 (1956) (0)
Proceedings of the Third International Symposium on Coenzyme Q, held in Austin, Texas, U.S.A., January 18-21, 1981 (1981) (0)
Cardiac outputs of control individuals and cancer patients and evidence of deficiencies of coenzyme Q10 and vitamin B6. (1980) (0)
[Coenzyme Q regarded as a vitamin]. (1970) (0)
Impressions of David E. Green by His Colleagues (1978) (0)
ANTAGONISTS OF SUBSTANCE P FROM EMPHASIS ON POSITION 11 (1984) (0)
Chlorinated Polycyclic Compounds. VII. Preparation and Reactions of the Anthracene Adduct of Mucochloric Acid. (1979) (0)
Vitamins: perspectives and propectives. (1960) (0)
Synthesis and biological activities of ethoxy analogs of coenzyme Q10. (1979) (0)
Intramolecular Oxidative Coupling of 2,2'-Ethylenedi-1,3-cyclohexanediones with Iron(III) Hexacyanoferrate(III). (1968) (0)
Coenzyme Q. 32. Coenzyme Q and the maintenance of sperm cells in vitro. (1963) (0)
Coenzyme Q10 (CoQ10) in heart muscle and cardiac function in patients treated with adriamycin (1985) (0)
Book Review:Current Topics in Cellular Regulation. Volume 8. Bernard L. Horecker, Earl R. Stadtman (1976) (0)
Critique of the Metabolism, Pharmacokinetics, and Toxicology of Coenzyme Q (1987) (0)
Patent Number : 5 , 470 , 947 45 ) Date of Patent : ( 54 CHRH ANTAGONISTS WITH LOW HISTAMINE RELEASE 75 Inventors : (2017) (0)
STRUCTURAL REQUIREMENTS IN POSITIONS 1,2,3 AND 6 OF THE LUTEINIZING HORMONE-RELEASING HORMONE (LH-RH) FOR ANTIOVULATORY ACTIVITY. PART 137 OF PEPTIDE HORMONES (1979) (0)
303 – INEW LH-RH ANALOGS WITH POTENT ANTAGONIST ACTIVITY (1978) (0)
Proceedings of the Fourth International Symposium on Coenzyme Q, held in Martinsried, Munich, FRG, November 6-9, 1983 (1984) (0)
SCHWEINITZII. THE IDENTIFICA- TION OF FERULIC ACID AS A NEW COFACTOR (2016) (0)
Contents, Vol. 59, Supplement 2, 1992 (1992) (0)
Science in the forefront. (1962) (0)
XIII Progress in the United States and in Japan on the Study of the Use of Coenzyme Q in Periodontal Disease (2010) (0)
PROSPECTIVES ON RESEARCH (1962) (0)
INHIBITION OF INFLUENZA VIRUS MULTIPLICATION BY ALKYL DERIVATIVES OF BENZIMIDAZOLE I. KINETIC ASPECTS OF INHIBITION BY 2,5-DIMETHYLBENZIMIDAZOLE AS MEASURED BY INFECTMTY TITRATIONS (2003) (0)
Position 10 is Critical for Antagonists of the Luteinizing Hormone-Releasing Hormone and for Inhibition of Ovulation in Rats (1990) (0)
SYNTHESIS OF SUBSTANCE P ANALOGS AND AGONISTIC AND ANTAGONISTIC ACTIVITIES (1980) (0)
Models for clinical disease. I. Biochemical cardiotoxicity of a coenzyme Q10-inhibitor in rats. (1976) (0)
Research on the chemistry of vitamin B12. (1952) (0)
NEW 2-METHYL-6-ALKYLAMINO-5,8-QUINOLINEQUINONES AND 1,2,3,4-TETRAHYDRO DERIVATIVES (1975) (0)
Synthesis of new 2-alkylmercapto-1,4-naphthoquinones as antimetabolites of coenzyme Q and as antitumor agents. (1978) (0)
BIOLOGICALLY ACTIVE THYMONES FRO THE THYMUS BACKGROUND OF THE INVENTION (2017) (0)
IMPROVED SYNTHESIS AND RESOLUTION OF β‐(3‐PYRIDYL)‐DL‐α‐ALANINE (1985) (0)
An Overview of Biochemical and Clinical Research on Coenzyme Q with Emphasis on Cardiomyopathy and Muscle Dystrophy (1987) (0)
Perspectives on the Discovery of Vitamin B12 (1990) (0)
Chromanol derivatives and methods for their preparation (1964) (0)
Chairman's Opening Remarks (2008) (0)
Coenzyme Q. 39. Studies on the biosynthesis of coenzyme Q10. (1963) (0)
VIII – Active Compounds and Vitamin B12 Antagonists (1968) (0)
Water-soluble vitamins. (1951) (0)
Family planning and other population controls. (Letter) (1968) (0)
Biotin. 5. Synthesis of dlMotin, dl-allobiatin and dl-epi-allobiotin. (1945) (0)
Improved assay of 4-hydroxybenzoic acid, biosynthetic precursor of coenzyme A. (1971) (0)
Study of tetrahydrobiopterin and 6-methyltetrahydropterin on alcohol dependence in mice. (1983) (0)
Letter from Karl Folkers to Joshua Lederberg (1951) (0)
INCORPORATION OF AMINO ACIDS INTO RIBONUCLEIC ACID BY RICHARD S. SCHWEET,* FREEMAN (2004) (0)
Gladys Anderson Emerson (1903-1984). A biographical sketch. (1985) (0)
Chairman's Closing Remarks (2008) (0)
Book Review:Exploratory Concepts in Muscular Dystrophy II. A. T. Milhorat (1976) (0)
Peptide hormones. 95. Inhibition of the activity of the luteinizing hormone-releasing hormone (LH-RH) by analogs with variations at positions 2, 3, and 6 and the carboxyl terminus (1977) (0)
Effect of folacin on biosynthesis of coenzyme Q10 from p-hydroxybenzoic acid in the chick. (1968) (0)
Deficiency ofCoenzymeQ10inGingival Tissue fromPatients withPeriodontal Disease (1971) (0)
Biochemical rationale and myocard: therapy of cardiomyopathy with coe (heart/cardiomyopathy/disease/bioenergetics) (2016) (0)
International symposium on recent advances in research on vitamins K and related quinones (vitamin K, ubiquinones or coenzymes Q, plastoquinones) in honor of Professor Henrik Dam. Session 2: Summary and prospects. (1966) (0)
New procedure for assay of p-hydroxybenzoic acid, precursor of coenzyme Q. (1970) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Karl August Folkers?

Karl August Folkers is affiliated with the following schools:

Karl August Folkers's Academic­Influence.com Rankings

Why Is Karl August Folkers Influential?

Karl August Folkers's Published Works

Published Works

What Schools Are Affiliated With Karl August Folkers?

Karl August Folkers's AcademicInfluence.com Rankings